Biomarker-guided antibiotic therapy in adult critically ill patients: a critical review
- PMID: 22824162
- PMCID: PMC3475044
- DOI: 10.1186/2110-5820-2-32
Biomarker-guided antibiotic therapy in adult critically ill patients: a critical review
Abstract
Biomarkers of infection, namely C-reactive protein and procalcitonin (PCT), are potentially useful in the diagnosis of infection as well as in the assessment of its response to antibiotic therapy. C-reactive protein variations overtime appears to have a good performance for the diagnosis of infection. Procalcitonin shows a better correlation with clinical severity. In addition, to overcome the worldwide problem of antibiotic overuse as well as misuse, biomarker guidance of antibiotic stewardship represents a promising new approach. In several randomized, controlled trials, including adult critically ill patients, PCT guidance was repeatedly associated with a decrease in the duration of antibiotic therapy. However, these trials present several limitations, namely high rate of patients' exclusion, high rate of algorithm overruling, long duration of antibiotic therapy in the control group, disregard the effect of renal failure on PCT level, and above all a possible higher mortality and higher late organ failure in the PCT arm. In addition, some infections (e.g., endocarditis) as well as frequent nosocomial bacteria (e.g., Pseudomonas aeruginosa) are not suitable to be assessed by PCT algorithms. Therefore, the true value of PCT-guided algorithm of antibiotic stewardship in assisting the clinical decision-making process at the bedside remains uncertain. Future studies should take into account the issues identified in the present review.
Figures
Similar articles
-
Biomarker-guided antibiotic therapy-strengths and limitations.Ann Transl Med. 2017 May;5(10):208. doi: 10.21037/atm.2017.04.04. Ann Transl Med. 2017. PMID: 28603723 Free PMC article. Review.
-
Ineffectiveness of procalcitonin-guided antibiotic therapy in severely critically ill patients: A meta-analysis.Int J Infect Dis. 2019 Aug;85:158-166. doi: 10.1016/j.ijid.2019.05.034. Epub 2019 Jun 21. Int J Infect Dis. 2019. PMID: 31229612
-
The efficacy of procalcitonin as a biomarker in the management of sepsis: slaying dragons or tilting at windmills?Surg Infect (Larchmt). 2013 Dec;14(6):489-511. doi: 10.1089/sur.2012.028. Epub 2013 Nov 25. Surg Infect (Larchmt). 2013. PMID: 24274059 Review.
-
Procalcitonin (PCT)-guided antibiotic stewardship in Asia-Pacific countries: adaptation based on an expert consensus meeting.Clin Chem Lab Med. 2020 Nov 26;58(12):1983-1991. doi: 10.1515/cclm-2019-1122. Clin Chem Lab Med. 2020. PMID: 31926074
-
Effectiveness of procalcitonin-guided antibiotic therapy to shorten treatment duration in critically-ill patients with bloodstream infections: a systematic review and meta-analysis.Infez Med. 2020 Mar 1;28(1):37-46. Infez Med. 2020. PMID: 32172259
Cited by
-
Community-acquired pneumonia: identification and evaluation of nonresponders.Ther Adv Infect Dis. 2013 Feb;1(1):5-17. doi: 10.1177/2049936112469017. Ther Adv Infect Dis. 2013. PMID: 25165541 Free PMC article. Review.
-
Usefulness of Serum Biomarkers in Predicting Anastomotic Leakage After Gastrectomy.Cancers (Basel). 2025 Jan 3;17(1):125. doi: 10.3390/cancers17010125. Cancers (Basel). 2025. PMID: 39796753 Free PMC article.
-
Comparison of the Diagnostic Accuracies of Procalcitonin and C-Reactive Protein for Spontaneous Bacterial Peritonitis in Patients with Cirrhosis: A Systematic Review and Meta-Analysis.Medicina (Kaunas). 2025 Jun 24;61(7):1134. doi: 10.3390/medicina61071134. Medicina (Kaunas). 2025. PMID: 40731765 Free PMC article.
-
Antibiotic prescription for respiratory tract infections in ventilated patients: where are we heading?Intensive Care Med. 2013 Sep;39(9):1644-6. doi: 10.1007/s00134-013-2983-z. Epub 2013 Jun 28. Intensive Care Med. 2013. PMID: 23812337 No abstract available.
-
Adherence to a procalcitonin-guided antibiotic treatment protocol in patients with severe sepsis and septic shock.Ann Intensive Care. 2018 Jun 4;8(1):68. doi: 10.1186/s13613-018-0415-5. Ann Intensive Care. 2018. PMID: 29869120 Free PMC article.
References
-
- Agency for Healthcare Research and Quality. Diagnostic groups with rapidly increasing costs by payer. 2001–2007. HCUP statistical brief 91. http://www.hcup-us.ahrq.gov/reports/statbriefs/sb91.pdf. - PubMed
-
- The outcome of patients with sepsis and septic shock presenting to emergency departments in Australia and New Zealand. Crit Care Resusc. 2007;9:8–18. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials